AbbVie

AbbVie

Employees:
29,500
Market Cap:
$130.42 billion
Revenue:
$28.22 billion
5 Year Trend:
8.9%
Net Income:
$5.53 billion
NYSE:
ABBV
Industry:
Chemical Manufacturing

AbbVie is a pharmaceutical company that discovers, develops and markets both biopharmaceuticals and small molecule drugs. It originated in 2013 as a spin-off of Abbott Laboratories. Wikipedia

AbbVie is a pharmaceutical company that discovers, develops and markets both biopharmaceuticals and small molecule drugs. It originated in 2013 as a spin-off of Abbott Laboratories. Wikipedia

Employees:
29,500
Market Cap:
$130.42 billion
Revenue:
$28.22 billion
5 Year Trend:
8.9%
Net Income:
$5.53 billion
NYSE:
ABBV
Industry:
Chemical Manufacturing
  • Dec 31 at 1:45 PM
    Best wishes for a healthy and #HappyNewYear.
  • Dec 21 at 2:00 PM
    Wishing you season's greetings & #happyholidays from all of us at AbbVie.
  • Dec 20 at 5:00 PM
    A day with our teams that work in inflammatory disease treatments is anything but typical. One thing is for certain, each day is filled with great science and great people. See what theyre working on: http://bit.ly/2CL5bf1
  • Dec 20 at 3:23 PM
    Building on over two decades of experience in inflammatory immune-mediated diseases. New data from the latest Phase 3 trial of our investigational JAK1 inhibitor - Read more here: http://bit.ly/2BHnjqP

Dec 31, 1:45 PM

Best wishes for a healthy and #HappyNewYear.

Dec 21, 2:00 PM

Wishing you season's greetings & #happyholidays from all of us at AbbVie.

Dec 20, 5:00 PM

A day with our teams that work in inflammatory disease treatments is anything but typical. One thing is for certain, each day is filled with great science and great people. See what theyre working on: http://bit.ly/2CL5bf1

Dec 20, 3:23 PM

Building on over two decades of experience in inflammatory immune-mediated diseases. New data from the latest Phase 3 trial of our investigational JAK1 inhibitor - Read more here: http://bit.ly/2BHnjqP

93 jobs at AbbVie

Jobs in